Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heimo Lagler

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2018
Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of ViennaSelma Tobudic, Christina Forstner, Heinz Burgmann, et al.
Infection|September 15, 2019
Real-world experience with dalbavancin therapy in gram-positive skin and soft tissue infection, bone and joint infectionSelma Tobudic, Christina Forstner, Heinz Burgmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 16, 2018
High seroprevalence of anti-Hepatitis E antibodies in Austrian patients with autoimmune hepatitisMichael Eder, Robert Strassl, Sandra Beinhardt, et al.
Infection|November 20, 2019
Correction to: Real‑world experience with dalbavancin therapy in gram‑positive skin and soft tissue infection, bone and joint infectionSelma Tobudic, Christina Forstner, Heinz Burgmann, et al.
Frontiers in Cellular and Infection Microbiology|June 9, 2020
Different Types of Coagulase Are Associated With 28-Day Mortality in Patients With <i>Staphylococcus aureus</i> Bloodstream InfectionsMatthias Karer, Manuel Kussmann, Franz Ratzinger, et al.
Antimicrobial Resistance and Infection Control|January 24, 2025
In vitro long-term exposure to chlorhexidine or triclosan induces cross-resistance against azoles in Nakaseomyces glabratusKathrin Spettel, Dominik Bumberger, Richard Kriz, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 10, 2020
Prevalence of anti-Hepatitis E antibodies and impact on disease severity in non-alcoholic fatty liver diseaseRafael Paternostro, Stefan Traussnigg, Katharina Staufer, et al.
Plos One|August 1, 2014
Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patientsBarbara Kiesewetter, Julius Lukas, Andreas Kuchar, et al.
Vaccine|July 8, 2018
Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseasesNicole Harrison, Wolfgang Poeppl, Manuel Miksch, et al.
Microbial Pathogenesis|April 16, 2009
Comparison of Austrian, Hungarian and Macedonian methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains in relation to prevalence of cytotoxin genesErika Kocsis, Heimo Lagler, Natasa Pesti, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 17, 2018
Dalbavancin as Primary and Sequential Treatment for Gram-Positive Infective Endocarditis: 2-Year Experience at the General Hospital of ViennaSelma Tobudic, Christina Forstner, Heinz Burgmann, et al.
Infection|September 15, 2019
Real-world experience with dalbavancin therapy in gram-positive skin and soft tissue infection, bone and joint infectionSelma Tobudic, Christina Forstner, Heinz Burgmann, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 16, 2018
High seroprevalence of anti-Hepatitis E antibodies in Austrian patients with autoimmune hepatitisMichael Eder, Robert Strassl, Sandra Beinhardt, et al.
Infection|November 20, 2019
Correction to: Real‑world experience with dalbavancin therapy in gram‑positive skin and soft tissue infection, bone and joint infectionSelma Tobudic, Christina Forstner, Heinz Burgmann, et al.
Frontiers in Cellular and Infection Microbiology|June 9, 2020
Different Types of Coagulase Are Associated With 28-Day Mortality in Patients With <i>Staphylococcus aureus</i> Bloodstream InfectionsMatthias Karer, Manuel Kussmann, Franz Ratzinger, et al.
Antimicrobial Resistance and Infection Control|January 24, 2025
In vitro long-term exposure to chlorhexidine or triclosan induces cross-resistance against azoles in Nakaseomyces glabratusKathrin Spettel, Dominik Bumberger, Richard Kriz, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 10, 2020
Prevalence of anti-Hepatitis E antibodies and impact on disease severity in non-alcoholic fatty liver diseaseRafael Paternostro, Stefan Traussnigg, Katharina Staufer, et al.
Plos One|August 1, 2014
Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patientsBarbara Kiesewetter, Julius Lukas, Andreas Kuchar, et al.
Vaccine|July 8, 2018
Predictors for influenza vaccine acceptance among patients with inflammatory rheumatic diseasesNicole Harrison, Wolfgang Poeppl, Manuel Miksch, et al.
Microbial Pathogenesis|April 16, 2009
Comparison of Austrian, Hungarian and Macedonian methicillin-resistant and methicillin-sensitive Staphylococcus aureus strains in relation to prevalence of cytotoxin genesErika Kocsis, Heimo Lagler, Natasa Pesti, et al.
Pageof 8